Länder Analysen: Schweiz

25.01.23 Novartis Underweight Barclays Capital
20.01.23 Givaudan Underweight Barclays Capital
20.01.23 DocMorris Sell UBS AG
19.01.23 DocMorris Sell UBS AG
19.01.23 Roche Underweight JP Morgan Chase & Co.
19.01.23 Roche Sell Deutsche Bank AG
18.01.23 Swiss Re Sell Goldman Sachs Group Inc.
13.01.23 UBS Underweight Barclays Capital
13.01.23 UBS Underweight Barclays Capital
12.01.23 Swiss Re Sell UBS AG
09.01.23 Givaudan Underperform Bernstein Research
06.01.23 Novartis Underperform Credit Suisse Group
06.01.23 Novartis Underweight Morgan Stanley
04.01.23 DocMorris Sell Deutsche Bank AG
03.01.23 Roche Underweight JP Morgan Chase & Co.
23.12.22 Novartis Underweight Barclays Capital
20.12.22 DocMorris Sell UBS AG
19.12.22 Givaudan Underweight JP Morgan Chase & Co.
19.12.22 Givaudan Sell UBS AG
16.12.22 Givaudan Sell Goldman Sachs Group Inc.
16.12.22 Givaudan Sell Goldman Sachs Group Inc.
14.12.22 Givaudan Underperform Jefferies & Company Inc.
14.12.22 Givaudan Underweight JP Morgan Chase & Co.
13.12.22 Givaudan Sell UBS AG
09.12.22 Novartis Sell Deutsche Bank AG
09.12.22 Givaudan Underperform Jefferies & Company Inc.
07.12.22 Novartis Sell Deutsche Bank AG
02.12.22 Swiss Re Sell UBS AG
01.12.22 Givaudan Underweight JP Morgan Chase & Co.
28.11.22 Givaudan Sell UBS AG
28.11.22 Givaudan Sell Goldman Sachs Group Inc.
23.11.22 Swiss Re Sell Goldman Sachs Group Inc.
22.11.22 Novartis Sell Deutsche Bank AG
21.11.22 Givaudan Sell UBS AG
21.11.22 UBS Underweight Barclays Capital
16.11.22 Givaudan Underperform Bernstein Research
15.11.22 DocMorris Sell Deutsche Bank AG
04.11.22 Swiss Re Underweight Morgan Stanley
02.11.22 Nestlé Underperform Jefferies & Company Inc.
31.10.22 Swiss Re Sell UBS AG
31.10.22 Givaudan Sell Goldman Sachs Group Inc.
27.10.22 UBS Sell Goldman Sachs Group Inc.
27.10.22 Novartis Sell Deutsche Bank AG
26.10.22 Novartis Underperform Credit Suisse Group
26.10.22 Novartis Underweight JP Morgan Chase & Co.
26.10.22 UBS Underweight Barclays Capital
26.10.22 Novartis Underweight Barclays Capital
25.10.22 DocMorris Underperform Credit Suisse Group
25.10.22 Novartis Sell Deutsche Bank AG
24.10.22 UBS Underweight Barclays Capital